Thromb Haemost 1999; 82(05): 1559-1560
DOI: 10.1055/s-0037-1614875
Letters to the Editor
Schattauer GmbH

Evidence for Antiphospholipid Antibodies in Hemophilic Children with Factor VIII Inhibitors

Rachelle Nuss
1   From the Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, Colorado, USA
,
Linda Jacobson
1   From the Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, Colorado, USA
,
W. E. Hathaway
1   From the Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, Colorado, USA
,
Marilyn Manco-Johnson
1   From the Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, Colorado, USA
› Author Affiliations
the Recombinate™ PUP Study Group
Further Information

Publication History

Received 05 May 1999

Accepted 15 June 1999

Publication Date:
09 December 2017 (online)

 

 
  • References

  • 1 Blanco AN, Cardozo MA, Candela M, Santarelli MT, Bianco RP, Larrarr M. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients. Thromb Haemost 1997; 77: 656-9.
  • 2 Cohen H, Mackie IJ, Anagnostopoulos N, Savage GF, Machin SJ. Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in haemophilia. J Clin Path 1989; 42: 629-33.
  • 3 Al-Saeed A, Makris M, Malia RG, Preston FE, Greaves M. The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatits C. Br J Haematol 1994; 88: 845-8.
  • 4 Maistre E, Wahl D, Perret-Guillaume C, Regnault V, Clarac S, Briquel M, Andre E, Lecompte T. A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants. Thromb Haemost 1998; 79: 237-8.
  • 5 Male C, Lechner K, Eichinger S, Kyrle P, Kapiotis S, Wank H, Kaider A, Pabinger I. Clinical significance of lupus anticoagulants in children. J Pediatr 1999; 134: 199-205.